PIMREG and bladder transitional cell carcinoma: Moreover, the expression levels of PIMREG in male patients with BLCA (Figure 7A, p = 0.0064), DLBC (Figure 7B, p = 0.027), HNSC (Figure 7C, p < 0.0001), KIRC (Figure 7D, p = 0.01) and LUAD (Figure 8E, p = 0.0013) were higher than the females.